Literature DB >> 26236139

Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

George DeMaagd, Ashok Philip.   

Abstract

This article-the first of a five-part series-discusses possible causes, symptoms, diagnosis, and goals for treatment of Parkinson's disease. Identifying diseases that have similar presentations is an important component of the diagnostic process.

Entities:  

Year:  2015        PMID: 26236139      PMCID: PMC4517533     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  130 in total

Review 1.  Treatment of Parkinson's disease: focus on quality of life issues.

Authors:  Ryan J Uitti
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Genetics meets environment: evaluating gene-environment interactions in neurologic diseases.

Authors:  Connie Marras; Samuel M Goldman
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 3.  Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

Authors:  Ronald B Postuma; Dag Aarsland; Paolo Barone; David J Burn; Christopher H Hawkes; Wolfgang Oertel; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

4.  Parkinson's disease symptoms: the patient's perspective.

Authors:  Marios Politis; Kit Wu; Sophie Molloy; Peter G Bain; K Ray Chaudhuri; Paola Piccini
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

5.  Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trial.

Authors:  Marjolein A van der Marck; Bastiaan R Bloem; George F Borm; Sebastiaan Overeem; Marten Munneke; Mark Guttman
Journal:  Mov Disord       Date:  2012-11-19       Impact factor: 10.338

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 7.  Designing prodrugs for the treatment of Parkinson's disease.

Authors:  Piera Sozio; Laura Serafina Cerasa; Anna Abbadessa; Antonio Di Stefano
Journal:  Expert Opin Drug Discov       Date:  2012-04-12       Impact factor: 6.098

8.  The interrelationship between non-motor symptoms in Atypical Parkinsonism.

Authors:  Chan-Nyoung Lee; Minjik Kim; Hye Mi Lee; Ji-Wan Jang; Seon-Min Lee; Do-Young Kwon; Kun-Woo Park; Seong-Beom Koh
Journal:  J Neurol Sci       Date:  2013-02-18       Impact factor: 3.181

9.  Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Authors:  Sara Hall; Annika Öhrfelt; Radu Constantinescu; Ulf Andreasson; Yulia Surova; Frederick Bostrom; Christer Nilsson; Widner Håkan; Hilde Decraemer; Katarina Någga; Lennart Minthon; Elisabet Londos; Eugeen Vanmechelen; Björn Holmberg; Henrik Zetterberg; Kaj Blennow; Oskar Hansson
Journal:  Arch Neurol       Date:  2012-11

10.  Tasks of attention augment rigidity in mild Parkinson disease.

Authors:  Dan A Mendonça; Mandar S Jog
Journal:  Can J Neurol Sci       Date:  2008-09       Impact factor: 2.104

View more
  89 in total

1.  Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.

Authors:  Biswadeep Das; Sriya Priyadarshini Dash; Swabhiman Mohanty; Paritosh Patel
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Adenosine decreases oxidative stress and protects H2O2-treated neural stem cells against apoptosis through decreasing Mst1 expression.

Authors:  Masoumeh Gholinejad; Iraj Jafari Anarkooli; Amirhossein Taromchi; Alireza Abdanipour
Journal:  Biomed Rep       Date:  2018-03-27

3.  Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device.

Authors:  Nikhil Mahadevan; Charmaine Demanuele; Hao Zhang; Dmitri Volfson; Bryan Ho; Michael Kelley Erb; Shyamal Patel
Journal:  NPJ Digit Med       Date:  2020-01-15

4.  Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Elaine Bandeira Cavalcanti Duarte; Laura Maria Ramos Miranda; Andore Guescel C Asano; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Neuromolecular Med       Date:  2019-05-22       Impact factor: 3.843

Review 5.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

6.  Neuroprotective effects of selegiline on rat neural stem cells treated with hydrogen peroxide.

Authors:  Alireza Abdanipour; Iraj Jafari Anarkooli; Saeed Shokri; Mehrdad Ghorbanlou; Vahid Bayati; Reza Nejatbakhsh
Journal:  Biomed Rep       Date:  2017-11-22

Review 7.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.

Authors:  Sachchida Nand Rai; Vivek K Chaturvedi; Payal Singh; Brijesh Kumar Singh; M P Singh
Journal:  3 Biotech       Date:  2020-11-10       Impact factor: 2.406

8.  Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Geidy E Serrano; Vellareddy Anantharam; Arthi Kanthasamy; Charles H Adler; Thomas G Beach; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 10.338

9.  Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Authors:  Nayron Medeiros Soares; Gabriela Magalhães Pereira; Vivian Altmann; Rosa Maria Martins de Almeida; Carlos R M Rieder
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

10.  Parkinson's family needs and caregiver mental health: A cross-cultural comparison between Mexico and the United States.

Authors:  Paul B Perrin; Richard S Henry; Emily K Donovan; Annahir N Cariello; Sarah K Lageman; Teresita Villaseñor; Joseph M Dzierzewski; Monica Arroyo; Judith Avila
Journal:  NeuroRehabilitation       Date:  2019-12-18       Impact factor: 2.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.